¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"urinary gonadotropin fragment/peptide"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
¿µ¹® urinary incontinence ÇÑ±Û ¿ä½Ç±Ý
¼³¸í   
  ¹æ±¤Á¶ÀÓ±Ù ¹× ¿äµµÁ¶ÀÓ±ÙÀÇ ¼öÀÇÀû Á¶ÀýÀÌ ¾ÈµÇ±â ¶§¹®¿¡ ¿ÀÁÜÀÌ Ç×»ó, ¶Ç´Â ¶§¶§·Î ºÒ¼öÀÇÀûÀ¸·Î ¹è¼³µÇ´Â °Í.
  
  Âü½Ç±Ý(true incontinence): ½Å°æ°èÅëÀÇ À̻󿡠ÀÇÇÑ Áø¼º¿ä½Ç±Ý. ½Å°æ°èÅëÀÇ ÀÌ»óÀ̹ǷΠġ·á´Â ºÒ°¡´ÉÇÑ °æ¿ì°¡ ¸¹´Ù.
  
  ±ä¹Ú½Ç±Ý(urge incontinence): ¹æ±¤ µîÀÇ ¿°Áõ¿¡ ÀÇÇÑ ±Þ¹Ú¿ä½Ç±Ý. ¿°Áõ¿¡ ÀÇÇÑ ÀÚ±ØÁõ»óÀ¸·Î ¿°ÁõÀ» Ä¡·áÇϸé ÀÚ¿¬È÷ ¼Ò½ÇµÈ´Ù.
  
  ½ºÆ®·¹½º½Ç±Ý(stress incontinence): °ñ¹ÝÀÇ ÇØºÎÇÐÀû ÁöÁö±¸Á¶ÀÇ ¾àÈ­¿¡ ÀÇÇØ ±âħ µî º¹¾ÐÀÌ Áõ°¡Çϴ »óȲ¿¡¼­ ¼ø°£ÀûÀ¸·Î ¹ß»ýÇϴ ¿ä½Ç±Ý. ´ë°³ ³ªÀÌ ¸¹Àº ¿©¼º¿¡¼­ ¸¹À¸¸ç, ´ÙÃâ»êÀÇ °æ·ÂÀ» °¡Áö°í ÀÖ´Ù. Ä¡·á´Â ¼ö¼úÀû ¹æ¹ýÀÌ´Ù.
  
  ³Ñħ½Ç±Ý(overflow incontinence): ¹æ±¤ÀÌÇϺÎÀ§ÀÇ Æó»ö¿¡ ÀÇÇØ ¿ÀÁÜÀÌ ¹è¼³µÇÁö ¸øÇÏ°í ¹æ±¤¿¡ Àú·ùµÇ´Ù°¡ ¹æ±¤ÀÇ ÀúÀå¿ë·®À» ³Ñ´Â ¼ø°£ ÁÖüÇÏÁö ¸øÇÏ°í ³ªÅ¸³ª´Â ¿ä½Ç±Ý.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • atrial natriuretic peptide
    ½É¹æ³ªÆ®·ýÀÌ´¢ÆéƼµå
  • brain natriuretic peptide
    ³ú³ªÆ®·ýÀÌ´¢ÆéƼµå
  • calcitonin gene-related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • gastrin-releasing peptide
    °¡½ºÆ®¸°À¯¸®ÆéƼµå
  • glucagon-like insulinotropic peptide
    ±Û·çÄ«°ïÀ¯»çÀν¶¸°ÀÚ±ØÆéÆ¼µå
  • glucagon-like peptide
    ±Û·çÄ«°ïÀ¯»çÆéƼµå
  • peptide
    ÆéƼµå
  • peptide bond
    ÆéƼµå°áÇÕ
  • peptide linkage
    ÆéƼµå°áÇÕ
  • signal peptide
    ½ÅÈ£ÆéƼµå
  • acute urinary retention
    ±Þ¼º¼Òº¯Á¤Ã¼, ±Þ¼º¿äÁ¤Ã¼
  • colonic urinary reservoir
    Àß·ÏâÀÚ´¢ÀúÀå¼Ò, ´ëÀå´¢ÀúÀå¼Ò
  • stress urinary incontinence
    º¹¾Ð¿ä½Ç±Ý, º¹¾Ð¿ÀÁÜ»õ±â, ½ºÆ®·¹½º¿ä½Ç±Ý
  • urinary
    1. ¿ä-, ¼Òº¯- 2. ºñ´¢-, ¿ä·Î-
  • urinary anomaly
    ºñ´¢±â±âÇü, ºñ´¢±âÀÌ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fallen fragment sign
    ³«ÇÏÆÄÆí¡ÈÄ
  • fracture fragment
    °ñÀýÁ¶°¢, °ñÀýÀýÆí
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
  • acute urinary retention
    ±Þ¼º¿äÃàÀû
  • urinary anomaly
    ºñ´¢±âÀÌ»ó, ºñ´¢±â±âÇü
  • colonic urinary reservoir
    Àß·èâÀÚ´¢ÀúÀå¼Ò, ´ëÀå´¢ÀúÀå¼Ò
  • urinary cast
    ¿ä¿øÁÖ
  • urinary continence
    ¹è´¢ÀÚÁ¦
  • urinary solute concentration
    ¿ä¿ëÁú³óµµ
  • urinary diversion
    ¿ä·ÎÀüȯ¼ú
  • urinary fistula
    ¿ä·Î»û±æ
  • urinary frequency
    ºó´¢
  • urinary incontinence
    ¿ä½Ç±Ý, ¿ÀÁÜÂñ²ûÁõ, ¿ÀÁÜ»õ±âÁõ
  • urinary organ
    ºñ´¢±â°ü
  • prostatic urinary sphincter
    Àü¸³»ù¿äµµÁ¶ÀÓ±Ù
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acentric fragment
    ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • fracture fragment
    °ñÀý Æí(Íéï¹ø¸).
  • fragment
    ¼¼Æí, ÆÄÆí(÷òø¸), ´ÜÆí(Ó¨ø¸), ºÐÀý, ÆíÀý, °ñÆí(Íéø¸).
  • fragment
    ÀýÆí, ºÐÀý, Á¶°¢
  • G-test=£¾gonadotropin stimulation test
    °í³ªµµÆ®·ÎÇÉ ÀÚ±ØÅ×½ºÆ®. µµÆ®·ÎÇÉÁö±Ø°Ë»ç
  • GnRH (gonadotropin releasing hormone)
    ¼º¼±ÀÚ±Ø(àõàÍí©Ð½)È£¸£¸óºÐºñ(ÝÂÝô)È£¸£¸ó
  • Gonadotropin-releasing hormone (GnRH)
    ¼º¼±ÀÚ±Ø(àõàÍí©Ð½)È£¸£¸ó ºÐºñ(ÝÂÝô)È£¸£¸ó
  • HCG=>human chorionic gonadotropin
    »ç¶÷À¶¸ð¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó
  • anterior pituitary gonadotropin
    (³ú)ÇϼöüÀü¿±(¼º)(ù»á÷ô÷îñç¨àõ) ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • gonadotropin
    ¼º¼± ÀÚ±Ø È¦¸ó
  • gonadotropin
    ¼º¼±ÀÚ±ØÈ£¸£¸ó
  • gonadotropin
    ¼º¼±ÀÚ±Ø(àõàÍí©Ð½)È£¸£¸ó.
  • gonadotropin
    ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • gonadotropin releasing hormone
    ¼º¼± ÀÚ±Ø È£¸£¸ó À¯¸®(ºÐºñÀÚ±Ø) È£¸£¸ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain gut peptide
    ³úÀå°üÆéƼµå
  • brain natriuretic peptide
    ³ú ³ªÆ®·ý ÀÌ´¢ ÆéƼµå
  • brain peptide
    ³úÆéƼµå.
  • c-peptide
    ¾¾-ÆéŸÀ̵å, ¾¾-ÆéƼµå
  • c-peptide
    c ÆéƼµå
  • c-peptide measurement
    c ÆéƼµåÃøÁ¤
  • calcitonin-gene related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • endogenous opiate peptide
    ³»À缺 ¿ÀÇÇ¿¡ÀÌÆ® ÆéŸÀ̵å, ³»À缺 ¾ÆÆí¾ç ÆéŸ À̵å.
  • neuro-peptide
  • opioid peptide
    ¾ÆÆí¾çÆéƼµå<ÆéŸÀ̵å>.
  • opioid peptide
    ¾ÆÆíÀ¯»çÆéƼµå<ÆéŸÀ̵å>.
  • parathyroid hormone-related peptide
    ºÎ°©»ó¼±(ÜùË£ßÒàÍ)È£¸£¸ó¿¬°ü(¡­æáμ)ÆéŸÀ̵å
  • peptide
    ÆéŸÀ̵å
  • peptide
    ÆéŸÀ̵å.
  • peptide antibiotics
    ÆÕƼµåÇ×»ýÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • peptide antibiotic
    ÆéŸÀ̵å Ç×»ýÁ¦(ù÷ßæð¥)
  • peptide bond
    ÆéŸÀÌµå °áÇÕ(Ì¿ùê)
  • peptide hormone
    ÆéŸÀ̵å È£¸£¸ó
  • peptide map
    ÆéŸÀ̵å Áöµµ(ò¢Óñ)
  • peptide synthetase
    ÆéŸÀÌµå ½ÅÅ×Å×À̽º
  • phosphate acceptor peptide
    Àλê¼ö¿ë(×òß«áôé») ÆéŸÀ̵å
  • signal peptide
    ½ÅÈ£(ãáûÜ)ÆéŸÀ̵å
  • S peptide
    S ÆéŸÀ̵å
  • spore peptide
    Æ÷ÀÚ(øàí­)
  • streptogenin peptide
    ½ºÆ®·¾ÅäÁ¦´Ñ ÆéŸÀ̵å
  • tryptic peptide
    Æ®¸³½ÅºÐÇØ(ÝÂú°) ÆéŸÀ̵å
  • vasoactive intestinal peptide
    Ç÷°ü ÀÛµ¿¼º(úìηíÂÔÑàõ) Àå(íó)
  • antigen-binding fragment
    Ç׿ø°áÇÕ(ù÷ê«Ì¿ùê) Á¶°¢
  • crystallizable fragment
    "°áÁ¤(Ì¿ïÜ) Á¶°¢, (ÔÒ) fc fragment"
  • Fab fragment
    Fab Á¶°¢
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TUG total urinary gonadotropin
UCG ultrasonic cardiography; urinary chorionic gonadotropin
UAP unlicensed assistive personnel; unstable angina pectoris; urinary acid phosphatase; urinary alkaline...
UTI urinary tract infection; urinary trypsin inhibitor
RFLPs Restriction Fragment Length Polymorphisms; Á¦ÇÑÈ¿¼Ò´ÜÆíÀå´ÙÇü
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
hCG Beta-human chorionic gonadotropin
CG Chorionic Gonadotropin
GTH II Gonadotropin II
GnRH-R Gonadotropin Releasing Hormone Receptor
GnRHa Gonadotropin releasing hormone analogs
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • urinary tract
    ¿ä·Î
  • amino fragment
    ¾Æ¹Ì³ë ÀýÆí
  • antigen binding fragment
    Ç׿ø °áÇÕ ºÎÀ§
  • bone fragment
    °ñÆí
  • carboxy fragment
    ź¼Ò ÀýÆí
  • detached fragment
    À¯¸®Æí, À¯¸® °ñÆí
  • enkephalin fragment
    ¿£ÄÉÆÈ¸° ºÐÀý
  • fracture fragment
    °ñÀý Æí
  • fragment
    ºÐÀý, ¼¼Æí, ÆÄÆí, ´ÜÆí, ÆíÀý, °ñÆí
    Å« Àüü°¡ ÆÄ±«µÇ¾î Çü¼ºµÈ ¼ÒÆí.
  • prodynorphin-derived fragment
    ÇÁ·Î´ÙÀ̳븣ÇÉ À¯·¡ ºÐÀý
  • root fragment
    Ä¡±Ù ÆÄÆí, Ä¡±Ù ÀýÆí
  • 9-amino acid peptide
    9-¾Æ¹Ì³ë»ê ÆéŸÀ̵å
  • brain peptide
    ³ú ÆéƼµå
  • corticotropin-like intermediate lobe peptide

    corticotropin-releasing factor (ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ¿ä¼Ò, ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ÀÎÀÚ

  • dynorphin-related peptide
    ´ÙÀ̳îÇÉ °ü·Ã ÆéƼµå
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
anterior pituitary gonadotropin Any gonadotropin of hypophysial origin; formerly used to designate a single hormone, because it was thought that the anterior hypophysis secreted only one gonadotropin.
Synonym: pituitary gonadotropic hormone.
(05 Mar 2000)
receptors, gonadotropin Those protein complexes or molecular sites on the surfaces of gonadal and other sensitive cells that bind gonadotropins and thereby modify the functions of those cells; hcg, lh, and fsh are the major specific gonadotropins.
(12 Dec 1998)
gonadotropin <endocrinology, hormone> A hormone capable of promoting gonadal growth and function.
The effects are usually limited to discrete functions or histological components of a gonad, such as stimulation of follicular growth or of androgen formation. Most gonadotrophin's exert their effects in both sexes, although the effect of a given gonadotrophin will differ in males and females.
Synonym: gonadotropin, gonadotropic hormone.
Origin: for gonadotrophin, fr. Gonad + G. Trophe, nourishment
(12 Sep 2002)
gonadotropin, human chorionic A human hormone made by chorionic cells (in the foetal part of the placenta), hCG is directed at the gonads and stimulates them. HCG becomes detectable (by immunologic means) within days of fertilization and forms the foundation of the common pregnancy tests. The level of hCG in maternal serum also enters as one component in the double and the triple screens used during pregnancy to assign risks of Down syndrome and other foetal disorders.
(12 Dec 1998)
gonadotropin-producing adenoma <tumour> A rare type of pituitary adenoma that produces FSH and LH; its cells can be identified only by immunochemical techniques.
(05 Mar 2000)
gonadotropin-releasing factor <hormone> The peptide hormone that control reproductive function.
It produced and released by the hypothalamus and controls the production and release of gonadotrophins from the pituitary gland.
It causes the production of luteinising hormone and follicle-stimulating hormone.
Synonym: gonadotropin-releasing factor, gonadotropin-releasing hormone, luteinizing hormone/follicle-stimulating hormone-releasing factor, gonadoliberin.
Origin: Gonad + L. Libero, to free, + -in
(19 Sep 2002)
gonadotropin-releasing hormone <hormone> The peptide hormone that control reproductive function.
It produced and released by the hypothalamus and controls the production and release of gonadotrophins from the pituitary gland.
It causes the production of luteinising hormone and follicle-stimulating hormone.
Synonym: gonadotropin-releasing factor, gonadotropin-releasing hormone, luteinizing hormone/follicle-stimulating hormone-releasing factor, gonadoliberin.
Origin: Gonad + L. Libero, to free, + -in
(19 Sep 2002)
chorionic gonadotropin A glycoprotein with a carbohydrate fraction composed of d-galactose and hexosamine, extracted from the urine of pregnant women and produced by the placental trophoblastic cells; its most important role appears to be stimulation, during the first trimester, of ovarian secretion of the oestrogen and progesterone required for the integrity of conceptus; it appears to play no significant role in the last two trimesters of pregnancy, as the oestrogen and progesterone are then formed by the placenta.
Synonym: anterior pituitary-like hormone, choriogonadotropin, chorionic gonadotropic hormone, chorionic gonadotrophic hormone, placenta gonadotropin, placentagonadotropin.
(05 Mar 2000)
chorionic gonadotropin, beta subunit, human The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (scan j clin lab invest suppl 1993;216:97-104)
(12 Dec 1998)
chorionic gonadotropin, human A human hormone made by chorionic cells (in the foetal part of the placenta), hCG is directed at the gonads and stimulates them. HCG becomes detectable (by immunologic means) within days of fertilization and forms the foundation of the common pregnancy tests. The level of hCG in maternal serum also enters as one component in the double and the triple screens used during pregnancy to assign risks of Down syndrome and other foetal disorders.
(12 Dec 1998)
chorionic gonadotropin unit The specific gonadotropic activity of 0.1 mg of the standard preparation of chorionic gonadotropin originating from the urine or placentas of pregnant women.
(05 Mar 2000)
placenta gonadotropin A glycoprotein with a carbohydrate fraction composed of d-galactose and hexosamine, extracted from the urine of pregnant women and produced by the placental trophoblastic cells; its most important role appears to be stimulation, during the first trimester, of ovarian secretion of the oestrogen and progesterone required for the integrity of conceptus; it appears to play no significant role in the last two trimesters of pregnancy, as the oestrogen and progesterone are then formed by the placenta.
Synonym: anterior pituitary-like hormone, choriogonadotropin, chorionic gonadotropic hormone, chorionic gonadotrophic hormone, placenta gonadotropin, placentagonadotropin.
(05 Mar 2000)
pregnant mare's serum gonadotropin <veterinary> Formed by the equine placenta. Its activity in animals is similar to that of the follicle-stimulating hormone; relatively ineffective in human beings.
Synonym: pregnant mare's serum gonadotropin.
(05 Mar 2000)
hormone, human chorionic gonadotropin A human hormone made by chorionic cells (in the foetal part of the placenta), hcg is directed at the gonads and stimulates them. Hcg becomes detectable (by immunologic means) within days of the time of fertilization. It therefore forms the foundation of most common pregnancy tests. The level of hcg in maternal serum enters as one component in the double and the triple screens used during pregnancy to assign risks of down syndrome and other foetal disorders.
(12 Dec 1998)
human chorionic gonadotropin A human hormone made by chorionic cells (in the foetal part of the placenta), hcg is directed at the gonads and stimulates them. Hcg becomes detectable (by immunologic means) within days of fertilization and forms the foundation of the common pregnancy tests. The level of hcg in maternal serum also enters as one component in the double and the triple screens used during pregnancy to assign risks of down syndrome and other foetal disorders.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á